NCT00994448
- Conditions
- Adolescent Methamphetamine Abuse, Behavior, Behavior, Addictive, +2 more
- Locations
-
- Behavioral Health Services- Lincoln Heights Family Recovery Center Los Angeles, California, United States
Clinical trial condition
Behavior, Addictive
Explore clinical trials studying Behavior, Addictive. Study availability and eligibility vary by location and protocol.
419 public trials
68 recruiting studies
Behavior, Addictive trial results
NCT01011829
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +7 more
- Locations
-
- UCLA Vine Street Clinic Los Angeles, California, United States
NCT01171677
- Conditions
- Alcohol Dependence, Alcohol-Related Disorders, Alcoholism, +9 more
- Locations
-
Not specified
NCT00830362
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +6 more
- Locations
-
- Medical University of South Carolina Charleston, South Carolina, United States
NCT00844701
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +6 more
- Locations
-
- Medical University of South Carolina Charleston, South Carolina, United States
Completed
Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse
NCT00671632
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +5 more
- Locations
-
- Baltimore, Maryland, United States
NCT01456338
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +8 more
- Locations
-
- Hartford Dispensary Hartford, Connecticut, United States
- Addiction Treatment Program at DHMC Lebanon, New Hampshire, United States
- Farnum Center Manchester, New Hampshire, United States
- WestBridge Manchester, New Hampshire, United States
NCT00685451
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +10 more
- Locations
-
- Fresh Start at Concord Hospital Concord, New Hampshire, United States
- Farnum Center Manchester, New Hampshire, United States
- Quitting Time Wilder, Vermont, United States
Completed
ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence
NCT00501631
- Conditions
- Alcohol Dependence, Alcohol-Related Disorders, Alcoholism, +7 more
- Locations
-
Not specified
NCT01391624
- Conditions
- Abstinence Syndrome, Addictive Behavior, Behavior, +3 more
- Locations
-
- Universidade Federal de São Paulo (Federal University of São Paulo); Departamento de Psicobiologia (Department of Psychobiology) São Paulo, Brazil